EDITAS Trademark

Trademark Overview


On Friday, April 20, 2018, a trademark application was filed for EDITAS with the United States Patent and Trademark Office. The USPTO has given the EDITAS trademark a serial number of 87886830. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 20, 2021. This trademark is owned by Editas Medicine, Inc.. The EDITAS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations
editas

General Information


Serial Number87886830
Word MarkEDITAS
Filing DateFriday, April 20, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 20, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 1, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEditas Medicine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Party NameEditas Medicine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02141

Trademark Events


Event DateEvent Description
Monday, December 20, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 20, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2021EXTENSION 5 GRANTED
Thursday, May 6, 2021EXTENSION 5 FILED
Monday, May 17, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 6, 2021TEAS EXTENSION RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020EXTENSION 4 GRANTED
Wednesday, November 11, 2020EXTENSION 4 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Sunday, June 14, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 14, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 14, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 14, 2020EXTENSION 3 GRANTED
Tuesday, April 14, 2020EXTENSION 3 FILED
Tuesday, April 14, 2020TEAS EXTENSION RECEIVED
Saturday, November 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2019EXTENSION 2 GRANTED
Thursday, October 31, 2019EXTENSION 2 FILED
Thursday, October 31, 2019TEAS EXTENSION RECEIVED
Wednesday, May 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 13, 2019EXTENSION 1 GRANTED
Monday, May 13, 2019EXTENSION 1 FILED
Monday, May 13, 2019TEAS EXTENSION RECEIVED
Tuesday, November 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 18, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 29, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 9, 2018ASSIGNED TO EXAMINER
Tuesday, May 1, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 24, 2018NEW APPLICATION ENTERED IN TRAM